Discover and read the best of Twitter Threads about #LBCT

Most recents (2)

#ACC19 #LBCT
@PCRonline
1PANACHE: Safety:Efficacy of Neladenoson Bialanate, Partial Adenosine A1 Receptor Agonist, in CHF & Preserved EF: PANACHE RCT

2PIONEER-HF: Initiation of Angiotensin-Neprilysin Inhibition after Acute Decomp CHF: Open-Label Extension of
PIONEER-HF Trial
3 Hopeful Heart Trial: Blended Collaborative Care for Treating ❤️Failure & Comorbid Depression: 12-Month Outcomes

4 CODIACS-QoL: Randomized Trial of Depression Screening After ACS: Comparison of Depression Identification After ACS-QOL & Cost Effectiveness
5 PARTNER 3: #TAVR or SAVR in Low-Risk Patients: Results of the PARTNER 3 Trial

6 Self-Expanding #TAVR or SAVR in Patients at Low Risk of Surgical Mortality

7 Outcomes of #TAVR with Balloon-Expandable Sapien3 Valve in Bicuspid Aortic Stenosis: An Analysis of STS/TVT Registry
Read 12 tweets
Proud to have led this #clusterRCT, presented @ESCCardio's #LBCT session & published today in @JAMA_current. Among 2495 adults (50% women) hospitalized for #HF, a transitional care model implemented in our publiclyfunded system did not ⬇️time to comp readmission/ED visit/death.
There was a significant improvement in the patient-reported outcomes of #discharge-preparedness, #qualityofcaretransition, and #QOL. However, there was no improvement in #QALY. The #PROs were not adjusted for multiplicity, but we will do post-hoc exploratory analysis.
Read 8 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just three indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!